Business
Neumora Therapeutics to Participate in Upcoming Conferences in November
WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in two investor conferences in November. Guggenheim 2nd Annual Healthcare Innovation Conference: Members of management will participate in a fireside chat on Mon
About this update from Neumora Therapeutics, Inc.
[{"type":"image","alt":"Neumora Therapeutics, Inc.","displaySize":"","headline":null,"caption":"Neumora Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":183,"height":40,"url":"https://media.zenfs.com/en/globenewswire.com/35035d45290d68b78910fa3d659951f0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/_ktBLath.hAycAMjdGu3YQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTM2MDtoPTc5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/35035d45290d68b78910fa3d659951f0","width":183,"height":40}},"lazy":false},{"type":"text","content":"WATERTOWN, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases, today announced that the Company will participate in two investor conferences in November.","length":379,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Guggenheim 2nd Annual Healthcare Innovation Conference: Members of management will participate in a fireside chat on Monday, November 10, 2025, at 2:30 p.m. ET in Boston, MA.","length":174,"tagName":"p"}]},{"val":[{"type":"text","content":"Stifel 2025 Healthcare Conference: Members of management will participate in a fireside chat on Wednesday, November 12, 2025, at 2:00 p.m. ET in New York, NY.","length":158,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":332,"olType":false},{"type":"text","content":"A live webcast of the events will be available on the events and presentations section of the Company’s website at www.neumoratx.com. A replay of the webcasts will be available following the completion of the events and will be archived for up to 30 days.","length":255,"tagName":"p"},{"type":"text","content":"About NeumoraNeumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the greatest medical challenges of our generation by taking a fundamentally different approach to the way treatments for brain diseases are developed. Our therapeutic pipeline currently consists of seven programs that target novel mechanisms of action for a broad range of underserved, prevalent diseases. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel thera...